بدائل البحث:
significantly declined » significant decline (توسيع البحث), significantly delayed (توسيع البحث), significantly decreased (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
significantly declined » significant decline (توسيع البحث), significantly delayed (توسيع البحث), significantly decreased (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
-
201
Descriptive analysis.
منشور في 2025"…Despite a general decrease in poverty, the rate among those aged 65 and older has increased. …"
-
202
-
203
-
204
Inequality measures of adolescent fertility rates in Sierra Leone, 2008–2019.
منشور في 2024الموضوعات: -
205
Trends in adolescent fertility rates in Sierra Leone by different inequality dimensions, 2008–2019.
منشور في 2024الموضوعات: -
206
-
207
-
208
-
209
-
210
-
211
-
212
-
213
-
214
Characteristics of study participants in women according to frailty groups.
منشور في 2025الموضوعات: -
215
-
216
-
217
Annual treatment frequencies in all eyes.
منشور في 2025"…<p>The number of anti-VEGF treatments, STTA, MA-PC, PPV, and total treatments (mean ± SD) significantly decreased from 2.6 ± 1.6, 0.3 ± 0.8, 0.6 ± 0.8, 0.1 ± 0.3, and 3.7 ± 1.7 preoperatively to 0.8 ± 1.9, 0.0 ± 0.2, 0.3 ± 1.0, 0.0, and 1.2 ± 2.2; at year 2 to 0.7 ± 2.0, 0.1 ± 0.6, 0.0 ± 0.2, 0.0 ± 0.2, and 1.0 ± 2.1; and at year 3 to 0.9 ± 2.2, 0.0, 0.2 ± 1.0, 0.0 ± 0.2, and 1.1 ± 3.1 (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …"
-
218
-
219
Time course of central retinal thickness (CRT) in all eyes.
منشور في 2025"…<p>Mean CRT (μm ± standard deviation) significantly decreased from 504.7 ± 118.2 μm preoperatively to 302.5 ± 60.5 at 1 month, 307.5 ± 64.4 at 3 months, 286.8 ± 49.0 at 6 months, 305.3 ± 79.5 at 12 months, 288.8 ± 79.1 at 24 months, and 295.2 ± 87.4 at 36 months (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …"
-
220
Annual treatment frequencies in recurrence and non-recurrence groups.
منشور في 2025"…<p>In the recurrence group, the respective treatment counts for anti-VEGF, STTA, MA-PC, PPV, and total treatments (mean ± standard deviation) in the year before surgery were 3.0 ± 1.4, 0.1 ± 0.3, 0.8 ± 1.0, 0.1 ± 0.3, and 4.0 ± 2.1, respectively. These significantly decreased to 2.3 ± 2.6, 0.1 ± 0.3, 0.8 ± 1.6, 0.0, and 3.1 ± 2.8 in the first year; 2.1 ± 2.8, 0.4 ± 1.0, 0, 0.1 ± 0.3, and 2.6 ± 2.8 in the second year; and 2.0 ± 2.2, 0, 0.6 ± 1.7, 0.1 ± 0.3, and 2.8 ± 3.5 in the third year (Kruskal–Wallis test, p < 0.001; Dunn’s test, *P < 0.05, **P < 0.01). …"